Kevin L. Schully

Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers

Si’Ana A. Coggins, Eric D. Laing, Cara Olsen et al. · Open Forum Infectious Diseases · 2021 · 70 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficient Delivery of the Toll-like Receptor Agonists Polyinosinic:Polycytidylic Acid and CpG to Macrophages by Acetalated Dextran Microparticles

Kevin J. Peine, Eric M. Bachelder, Zachary VanGundy et al. · Molecular Pharmaceutics · 2013 · 57 citations

Pharmacy, Immunology, Pharmaceutics +16

Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational <i>Bacillus Anthracis</i> Exposure

Matthew D. Gallovic, Kevin L. Schully, Matthew G. Bell et al. · Advanced Healthcare Materials · 2016 · 52 citations

Pharmacy, Biotechnology, Immunology +17

Evaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis

Christopher Duplessis, Michael J. Gregory, Kenneth G. Frey et al. · Journal of Intensive Care · 2018 · 34 citations · Full text

Veterinary Medicine, Immunology, Molecular Medicine +17

Rapid Vaccination Using an Acetalated Dextran Microparticulate Subunit Vaccine Confers Protection Against Triplicate Challenge by Bacillus Anthracis

Kevin L. Schully, Sadhana Sharma, Kevin J. Peine et al. · Pharmaceutical Research · 2013 · 33 citations

Veterinary Medicine, Immunology, Microbiology +14